Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS46000929BKPyvENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS10000961HBVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS10000962HBVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS10024388HBVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS10026682HBVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS10024387HBVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS10026683HBVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS10042402HBVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS30010211HIVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TVIS30085355HIVENSG00000168959.15protein_codingGRM5NoNo2915P41594
TCGA Plot Options
Drug Information
GeneGRM5
DrugBank IDDB00659
Drug NameAcamprosate
Target IDBE0001192
UniProt IDP41594
Regulation Typeantagonist
PubMed IDs15963001; 18377703
CitationsDe Witte P, Littleton J, Parot P, Koob G: Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action. CNS Drugs. 2005;19(6):517-37.@@Blednov YA, Harris RA: Metabotropic glutamate receptor 5 (mGluR5) regulation of ethanol sedation, dependence and consumption: relationship to acamprosate actions. Int J Neuropsychopharmacol. 2008 Sep;11(6):775-93. doi: 10.1017/S1461145708008584. Epub 2008 Apr 1.
GroupsApproved; Investigational
Direct ClassificationOrganosulfonic acids
SMILESCC(=O)NCCCS(O)(=O)=O
Pathways
PharmGKBPA10344
ChEMBLCHEMBL1201293